Related Experiment Video
Updated: Jan 18, 2026

05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
677
Optimal Management of High-risk Stage I Nonseminoma Germ Cell Tumor: Active Intervention is the Preferred Option
Scott M Gilbert1, Wade J Sexton1
1H. Lee Moffitt Cancer Center & Research Institute, Department of Genitourinary Oncology, Tampa, FL, USA.
European Urology Focus
|October 1, 2019
Abstract:
While there is still debate and uncertainty regarding the best management strategy for clinical stage IB nonseminoma germ cell tumor, adjuvant treatment with chemotherapy or surgery is associated with a markedly lower risk of recurrence for men with high-risk features and provides more definitive disease control and lower overall exposure to chemotherapy for patients who do experience recurrence.

